COLVIN PAUL

CIK 00015139002 companiesWILMINGTON, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001513900

Recent Transactions

39 trades

Award
Syneos Health, Inc.
Class A Common Stock
2021-03-02+1,048→ 30,952 total
Award
Syneos Health, Inc.
Class A Common Stock
2021-03-02+1,629→ 29,904 total
Sale
Syneos Health, Inc.
Class A Common Stock
2021-02-01$74.82/sh−8,486→ 28,275 total
Award
Syneos Health, Inc.
Class A Common Stock
2021-01-15+11,463→ 36,761 total
Tax Payment
Syneos Health, Inc.
Class A Common Stock
2021-01-15$75.42/sh−1,768→ 25,298 total
Tax Payment
Syneos Health, Inc.
Class A Common Stock
2021-01-08$73.59/sh−2,031→ 27,066 total
Tax Payment
Syneos Health, Inc.
Class A Common Stock
2021-01-02$67.36/sh−249→ 29,097 total
Purchase
Syneos Health, Inc.
Class A Common Stock
2020-03-19$36.65/sh+1,300→ 26,855 total
Award
Syneos Health, Inc.
Class A Common Stock
2020-03-05+2,491→ 29,346 total
Award
Syneos Health, Inc.
Class A Common Stock
2020-01-15+11,862→ 25,555 total
Tax Payment
Syneos Health, Inc.
Class A Common Stock
2020-01-08$59.96/sh−1,404→ 13,693 total
Tax Payment
Syneos Health, Inc.
Class A Common Stock
2020-01-02$59.51/sh−249→ 15,097 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−15,992→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−11,041→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−30,000→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-12-05$33.25/sh−45→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Restricted Stock Units
2011-12-05−10,000→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−31,052→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−11,386→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−3,753→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−16,000→ 0 total
Disposition to Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-12-05−15,526→ 0 total
Discretionary Transaction
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-11-22$24.98/sh+20→ 45 total
Discretionary Transaction
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-06-30$24.16/sh+24→ 24 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-27$20.45/sh+5,333→ 5,659 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-27$28.70/sh−5,659→ 0 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-05-27−326→ 3,753 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-05-27−5,333→ 11,041 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-27$19.94/sh+326→ 326 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-26$19.94/sh+100→ 100 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-26$28.70/sh−100→ 0 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-05-26−100→ 4,079 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-20$19.94/sh+413→ 413 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-05-20−413→ 4,179 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-20$20.45/sh+187→ 600 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-05-20$29.01/sh−600→ 0 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-05-20−187→ 16,374 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-02-23+30,000→ 30,000 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Restricted Stock Units
2011-02-23+10,000→ 10,000 total

Companies

Recent Filings

Address

929 NORTH FRONT STREET

WILMINGTON, NC, 28401

View on SEC.gov